Insights from 2023 SABCS
S

SABCS 2023 Insights: "VERITAC-3 Study, With a Lead-in, of 1L Vepdegestrant + Palbociclib vs. Letrozole + Palbociclib in ER+/HER2- Advanced BC"

By Insights from 2023 SABCS FEATURING Seth Wander
By Insights from 2023 SABCS FEATURING Seth Wander
168 views
January 3, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Related Content

AUTOPLAY
Fred Hutchinson Cancer Center

Breast Oncology, Best of 2024

Wed, Oct 30, 2024
25:08
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

Feat. S. Tolaney, H. Rugo
12:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

Feat. P. Tarantino
11:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, …

Feat. P. Tarantino
07:23
Total Health

Advanced Stage HR+ BC: Fine-Tuning Sequential Endocrine and Targeted…

Feat. R. O'Regan
03:40
Integrity CE

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia
14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
09:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…

Feat. E. Hamilton
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
27:01
Scripps Health

CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC

Feat. S. Sammons
22:34
Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney
27:04
Fengting Yan

Cancer Screening Molecular Tools

10:34
Sara Tolaney

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
16:19
Wassim Mchayleh

Optimizing Adjuvant Treatment in High-Risk HR+/HER2- eBC: Patient Se…

21:01
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Panel Discussion: "Key Updates in Breast Cance…

Feat. S. Tolaney, H. Rugo
17:12
UNC Lineberger Comprehensive Cancer Center

Strategies for Managing Toxicities of Oral Oncolytics in Breast Canc…

Feat. A. Faso, B. Patel, K. Chen
12:07
Sara Tolaney

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
13:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NATALEE Trial - Baseline Characteristics …

Feat. D. Yardley
21:31
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Summary: "Community Oncologists Highlights&quo…

Feat. S. Tolaney, H. Rugo